Alzheimer Drug Review Day Seven Silence Clears Two Trading Weeks
Seven days after Cochrane called anti-amyloid efficacy trivial, the FDA, CMS, Biogen, and Lilly remain silent — the institutional pattern is now policy, not delay.
The news. The narrative. The timeline.
Bureau: Chicago
Seven days after Cochrane called anti-amyloid efficacy trivial, the FDA, CMS, Biogen, and Lilly remain silent — the institutional pattern is now policy, not delay.
Day 10: Airgas is cutting academic-lab helium 50 percent, NIH stays silent on MRI triage, and UK hospitals log a tenth delivery-less week.
The first cattle detections in four months surfaced the same week a peer-reviewed paper found H5N1 RNA in an asymptomatic bull — two silent routes compounding in real time.
The CDC count is now running ahead of last year's full total by summer — and the secretary's testimony-era framing has not been revised.
FDA's April 14 off-target CRISPR sequencing draft guidance runs Day Nine of its 90-day comment window with industry responses still in drafting and the July 14 close fixed.
Monday's 37-degree wind chill delivered a 2:01:52 Korir course record and — two days later — a BAA medical-tent count running below the 8-9% field-load threshold of a warm race.
Heritage's NEST blueprint delivers the baby-bonus dollar figure: $2,500 seed, $4,418 Family & Marriage credit, $2,000 stay-at-home supplement, $5,000 wedding match.
Volume 75 Issue 14 on April 16 ran invasive Hib clusters among homeless adults; Issue 15 drops Thursday and the paper is reading what it carries against what it does not.
A 10,217-person SHARE cohort's flat decline curve continues to read against the loneliness-as-dementia framing, and the April 14 finding has not been challenged in the eight days since publication.
The eldest of the performing Osmonds died Monday evening at his home in Lehi, Utah, surrounded by his wife Suzanne and their eight sons.